Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Repressing endogenous CCR5 gene expression in cells using engineered zinc finger proteins

Repressing endogenous CCR5 gene expression in cells using engineered zinc finger proteins

US Patent 8268618 · Granted Sep 18, 2012

Estimated economic value: $5,492,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Neural regenerating cells with alterations in DNA methylation2025
Hematopoietic growth factor proteins and analogs thereof and angiotensin convert2025
Methods and compositions for modulating angiogenesis and vasculogenesis2024
Oligodendrocyte progenitor cell compositions2024
Methods and compositions for modulating peripheral immune function2024
Methods and compositions for modulating angiogenesis and vasculogenesis2022
Hematopoietic growth factor proteins and analogs thereof and angiotensin convert2022
Methods and use of growth hormone supergene family protein analogs for treatment2020
Methods and compositions for modulation of migration of neurogenic cells2020
Methods and compositions for modulating peripheral immune function2020
Cysteine analogs of exendin-42019
Method to increase the number of circulating platelets by administering PEGylate2019